Literature DB >> 15058281

Herbal alkaloid tetrandrine: fron an ion channel blocker to inhibitor of tumor proliferation.

Gang Wang1, José R Lemos, Costantino Iadecola.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15058281     DOI： 10.1016/j.tips.2004.01.009

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  31 in total

1.  Induction of apoptosis by 3-amino-6-(3-aminopropyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline via modulation of MAPKs (p38 and c-Jun N-terminal kinase) and c-Myc in HL-60 human leukemia cells.

Authors:  Eun-Jung Park; Evgeny Kiselev; Martin Conda-Sheridan; Mark Cushman; John M Pezzuto
Journal:  J Nat Prod       Date:  2011-12-07       Impact factor: 4.050

2.  Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancer.

Authors:  Bai-Cheng He; Jian-Li Gao; Bing-Qiang Zhang; Qing Luo; Qiong Shi; Stephanie H Kim; Enyi Huang; Yanhong Gao; Ke Yang; Eric R Wagner; Linyuan Wang; Ni Tang; Jinyong Luo; Xing Liu; Mi Li; Yang Bi; Jikun Shen; Gaurav Luther; Ning Hu; Qixin Zhou; Hue H Luu; Rex C Haydon; Yingming Zhao; Tong-Chuan He
Journal:  Mol Pharmacol       Date:  2010-10-26       Impact factor: 4.436

Review 3.  Low-voltage-activated T-type Ca2+ channel inhibitors as new tools in the treatment of glioblastoma: the role of endostatin.

Authors:  Yuan Zhang; Hua Wang; Zhiyuan Qian; Bo Feng; Xianyang Zhao; Xinghong Jiang; Jin Tao
Journal:  Pflugers Arch       Date:  2014-01-10       Impact factor: 3.657

4.  c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine.

Authors:  Pankaj Chaudhary; Jamboor K Vishwanatha
Journal:  Biochem Pharmacol       Date:  2014-08-30       Impact factor: 5.858

5.  Traditional Chinese medicines and their active ingredients sensitize cancer cells to TRAIL-induced apoptosis.

Authors:  Bingyu Sun; Yongqiang Liu; Danhua He; Jinke Li; Jiawei Wang; Wulin Wen; Ming Hong
Journal:  J Zhejiang Univ Sci B       Date:  2021-03-15       Impact factor: 3.066

6.  Tetrandrine inhibits activation of rat hepatic stellate cells in vitro via transforming growth factor-beta signaling.

Authors:  Yuan-Wen Chen; Jian-Xin Wu; Ying-Wei Chen; Ding-Guo Li; Han-Ming Lu
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

7.  Inhibition of T-type Ca²⁺ channels by endostatin attenuates human glioblastoma cell proliferation and migration.

Authors:  Yuan Zhang; Junhong Zhang; Dongsheng Jiang; Dong Zhang; Zhiyuan Qian; Chunfeng Liu; Jin Tao
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

8.  Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor -kappaB activation.

Authors:  Dei Kui Zhang; Li Na Cheng; Xiao Li Huang; Wei Shi; Jun Ying Xiang; Hua Tian Gan
Journal:  Int J Colorectal Dis       Date:  2008-08-07       Impact factor: 2.571

Review 9.  TRPM8: a potential target for cancer treatment.

Authors:  Zhaoguo Liu; Hongyan Wu; Zhonghong Wei; Xu Wang; Peiliang Shen; Siliang Wang; Aiyun Wang; Wenxing Chen; Yin Lu
Journal:  J Cancer Res Clin Oncol       Date:  2016-01-23       Impact factor: 4.553

10.  Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling.

Authors:  Di-Fei Shen; Qi-Zhu Tang; Ling Yan; Yan Zhang; Li-Hua Zhu; Lang Wang; Chen Liu; Zhou-Yan Bian; Hongliang Li
Journal:  Br J Pharmacol       Date:  2010-01-25       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.